Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
113.84
-0.88 (-0.77%)
Feb 21, 2025, 4:00 PM EST - Market closed
Revvity Employees
Revvity had 11,500 employees as of December 31, 2023. The number of employees decreased by 5,200 or -31.14% compared to the previous year.
Employees
11,500
Change (1Y)
-5,200
Growth (1Y)
-31.14%
Revenue / Employee
$239,567
Profits / Employee
$23,512
Market Cap
13.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
Dec 31, 2022 | 16,700 | 0 | - |
Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
Dec 31, 2019 | 13,000 | 500 | 4.00% |
Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
Dec 31, 2016 | 8,000 | 0 | - |
Dec 31, 2015 | 8,000 | 300 | 3.90% |
Dec 31, 2014 | 7,700 | 100 | 1.32% |
Dec 31, 2013 | 7,600 | 100 | 1.33% |
Dec 31, 2012 | 7,500 | 300 | 4.17% |
Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
Dec 31, 2009 | 8,200 | 300 | 3.80% |
Dec 31, 2008 | 7,900 | -800 | -9.20% |
Dec 31, 2007 | 8,700 | 200 | 2.35% |
Dec 31, 2006 | 8,500 | 500 | 6.25% |
Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
Dec 31, 2004 | 10,000 | 0 | - |
Dec 31, 2003 | 10,000 | -700 | -6.54% |
Dec 31, 2002 | 10,700 | -100 | -0.93% |
Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
Dec 31, 2000 | 12,500 | 500 | 4.17% |
Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
Dec 31, 1996 | 15,000 | 0 | - |
Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
RVTY News
- 1 day ago - Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group - Business Wire
- 1 day ago - Revvity to Present at Upcoming Investor Conferences - Business Wire
- 21 days ago - Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending - Reuters
- 21 days ago - Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 - Business Wire
- 4 weeks ago - Revvity Board Declares Quarterly Dividend - Business Wire
- 4 weeks ago - Revvity Ignites Scientific Breakthroughs at SLAS2025 - Business Wire
- 5 weeks ago - Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing - Business Wire